Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.
Leung JM, Chen V, Hollander Z, Dai D, Tebbutt SJ, Aaron SD, Vandemheen KL, Rennard SI, FitzGerald JM, Woodruff PG, Lazarus SC, Connett JE, Coxson HO, Miller B, Borchers C, McManus BM, Ng RT, Sin DD. Leung JM, et al. Among authors: connett je. PLoS One. 2016 Aug 15;11(8):e0161129. doi: 10.1371/journal.pone.0161129. eCollection 2016. PLoS One. 2016. PMID: 27525416 Free PMC article.
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD; Canadian Respiratory Research Network (CRRN). Leitao Filho FS, et al. Among authors: connett je. Respir Res. 2018 Feb 14;19(1):30. doi: 10.1186/s12931-018-0733-z. Respir Res. 2018. PMID: 29444682 Free PMC article. Clinical Trial.
Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
Hernández Cordero AI, Yang CX, Li X, Milne S, Chen V, Hollander Z, Ng R, Criner GJ, Woodruff PG, Lazarus SC, Connett JE, Han MK, Martinez FJ, Reed RM, Man SFP, Leung JM, Sin DD. Hernández Cordero AI, et al. Among authors: connett je. Respir Res. 2021 Dec 22;22(1):316. doi: 10.1186/s12931-021-01911-9. Respir Res. 2021. PMID: 34937547 Free PMC article. Clinical Trial.
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.
Woodruff PG, Chatila W, Connett JE, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Marchetti N, Rogers TJ, Scanlon PD, Sin DD, Voelker H, Wendt C, Albert RK; COPD Clinical Research Network. Woodruff PG, et al. Among authors: connett je. Eur Respir J. 2014 Jan;43(1):295-8. doi: 10.1183/09031936.00140613. Epub 2013 Oct 17. Eur Respir J. 2014. PMID: 24136332 Free PMC article. Clinical Trial. No abstract available.
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
Woodruff PG, Albert RK, Bailey WC, Casaburi R, Connett JE, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Harnden SM, Kim V, Marchetti N, Martinez FJ, McEvoy CE, Niewoehner DE, Reilly JJ, Rice K, Scanlon PD, Scharf SM, Sciurba FC, Washko GR, Lazarus SC; Copd Clinical Research Network. Woodruff PG, et al. Among authors: connett je. COPD. 2011 Feb;8(1):21-9. doi: 10.3109/15412555.2010.540273. COPD. 2011. PMID: 21299475 Free PMC article. Clinical Trial.
Serum Bilirubin and Disease Progression in Mild COPD.
Apperley S, Park HY, Holmes DT, Man SFP, Tashkin D, Wise RA, Connett JE, Sin DD. Apperley S, et al. Among authors: connett je. Chest. 2015 Jul;148(1):169-175. doi: 10.1378/chest.14-2150. Chest. 2015. PMID: 25539285 Free PMC article.
281 results